KEYNOTE-177 Archives - Medical Conferences

Pembrolizumab benefits survival in MSI-H/dMMR metastastic colorectal cancer

Presented By

Prof. Thierry André, Sorbonne University, France

Trial

Phase 3, KEYNOTE 177

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 23:32

Presented By

Dr Kai-Keen Shiu, University College London Hospitals NHS Foundation Trust, UK

Trial

Phase 3, KEYNOTE-177

Conference

ASCO GI 2021

Type

Peer-reviewed article

12 March 2021 11:52

Expert

Prof. Thierry André, St Antoine Hospital, France

Trial

Phase 3, KEYNOTE-177

Conference

ASCO 2020

17 September 2020 14:55